SCHEMBL4906642

SCHEMBL4906642

CCN(c1ccc(-c2ccc(OC(F)(F)F)cc2)cc1)S(=O)(=O)c1ccc(C)c(C(=O)O)c1

nearest known ligand 0.54

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
HCRTR2 O43614 1/20 0.54
LMNA P02545 2/20 0.53
ALDH1A1 P00352 2/20 0.47
HPGD P15428 1/20 0.47
ALOX15 P16050 1/20 0.47
HSD17B10 Q99714 1/20 0.47
SERPINE1 P05121 3/20 0.46
GAA P10253 1/20 0.46
HTT P42858 1/20 0.46
TRPM8 Q7Z2W7 6/20 0.45
NR3C1 P04150 1/20 0.45
ESR1 P03372 1/20 0.45
KDM4E B2RXH2 1/20 0.44
PKM P14618 1/20 0.44
CNR2 P34972 1/20 0.43
KEAP1 Q14145 1/20 0.43
NFE2L2 Q16236 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4907142 0.94 HCRTR2 (0.54) HCRTR2LMNAALDH1A1HPGDALOX15
SCHEMBL4899803 0.91 HCRTR2 (0.53) HCRTR2LMNAALDH1A1SERPINE1GAA
SCHEMBL4897462 0.89 HCRTR2 (0.51) HCRTR2LMNAALDH1A1HPGDALOX15
SCHEMBL4898232 0.87 LMNA (0.54) LMNAALDH1A1HPGDALOX15HSD17B10
SCHEMBL4906350 0.87 LMNA (0.55) HCRTR2LMNAALDH1A1GAAHTT
SCHEMBL4903714 0.86 LMNA (0.56) LMNAALDH1A1HPGDALOX15HSD17B10
SCHEMBL4897605 0.86 LMNA (0.54) HCRTR2LMNAALDH1A1GAAHTT
SCHEMBL4904116 0.85 LMNA (0.56) HCRTR2LMNAALDH1A1HPGDALOX15
SCHEMBL4905703 0.85 LMNA (0.62) HCRTR2LMNAALDH1A1HPGDALOX15
SCHEMBL4904544 0.85 HCRTR2 (0.53) HCRTR2LMNAALDH1A1SERPINE1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER INC 2005-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PPARA, PPARG, PPARD HCRTR2 3933/4885LMNA 319/4885ALDH1A1 2956/4885
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PPARA, PPARG, PPARD HCRTR2 3933/4885LMNA 319/4885ALDH1A1 2956/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.